Date of event
Continuing Education Credits
Hepatitis B SIG
- Anna S. Lok, MD, FAASLD
- Kali Zhou, MD, MAS
- Hannah Lee, MD
- Yao-Chun Hsu, MD, MSc, PhD
- Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
- Yee Hui Yeo, MD, MSc
This live webinar will focus on identifying areas of unmet needs and developing a research career. We will have four presenters share their career experiences. An experienced professional will share her experience on doing clinical research in hepatitis B and thoughts on selecting between research, quality improvement or medical educator. Three young investigators will present their perspectives on how his or her career started and share in future career plans.
AASLD is grateful to AbbVie for its generous sponsorship of AASLD Webinars
Anna S. Lok, MD, FAASLD
Anna S. Lok, MD, FAASLD graduated from the University of Hong Kong Medical School. She completed her hepatology training in London under Dame Sheila Sherlock at the Royal Free Hospital in London. She was faculty at the University of Hong Kong before moving to the United States. She joined the University of Michigan in 1995 as director of the hepatology program and in 2016 became assistant dean for clinical research. Dr. Lok’s research focuses on natural history and treatment of hepatitis B and C. She has published more than 550 papers on viral hepatitis and liver diseases, including five editions of the American Association for the Study of Liver Diseases (AASLD) guidelines on "Hepatitis B."
Dr. Lok has mentored more than 50 residents, fellows, and faculty, many of whom are now full professors and heads of hepatology units. Dr. Lok received many awards throughout her career including awards from the Hepatitis B Foundation, the American Gastroenterological Association, the Canadian Association for the Study of the Liver, the European Association for the Study of the Liver, and the Distinguished Service Award from the AASLD in 2011. Dr. Lok served as associate editor of HEPATOLOGY (2002-2006), co-editor of Journal of Viral Hepatitis (2007-2009), senior associate editor of GASTROENTEROLOGY (2011-2012), and president of AASLD (2017).
Kali Zhou, MD, MAS
Kali Zhou, MD, MAS is a transplant hepatologist and assistant professor in the Division of Gastrointestinal and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, California. She received her medical degree from Feinberg School of Medicine at Northwestern University, completed an internal medicine residency at the University of California, Los Angeles, and a T32 gastroenterology and transplant hepatology fellowship at the University of California, San Francisco, where she also completed a master’s in clinical research. She holds committee positions in the AASLD HBV and Public Health SIGs.
Dr. Zhou investigated the epidemiology of HCV in Southern China as a Fulbright scholar and has published numerous peer-reviewed manuscripts and reviews related to epidemiology and health services delivery for chronic HBV infection. Her current research program focuses on disparities in liver cancer and utilizing novel geospatial approaches to improve cancer equity and outcomes for multi-ethnic populations. She is also grant funded to study the impact of immigration and acculturation on completing guideline-based HBV metrics. She was awarded the Early Career Investigator Award in Clinical/Translational Science by AASLD for her work.
Hannah Lee, MD
Hannah Lee, MD is an assistant professor of medicine at Virginia Commonwealth University Medical Center in Richmond, Virginia in the division of GI, Hepatology and Nutrition. She has a strong interest in liver cancer and viral hepatitis, particularly hepatitis B. She was previously the director of the Asian Pacific Liver Health Program in Boston Chinatown at Tufts Medical Center. She is currently co-director of the multidisciplinary liver cancer program at VCU and practices both transplant and general hepatology. She is involved in multicenter studies evaluating the natural history of HBV and HCC.
Dr. Lee’s career has been focused on addressing health disparities in liver disease, particularly among disproportionately affected minority groups with chronic hepatitis B. Some of her work has focused on screening and linkage to care. She has been involved in education and outreach both locally and nationally in addressing liver health disparities in hepatitis B and hepatocellular carcinoma among various communities in the United States. Dr. Lee currently serves on the AASLD Hepatitis B Special Interest Group's Leadership Steering Committee and is co-chair of the Education Subcommittee. She also serves as a committee member on the AASLD Public Policy Committee.
Yao-Chun Hsu, MD, MSc, PhD
Yao-Chun Hsu, MD, MSc, PhD is currently an associate professor at the school of medicine, I-Shou University, and the director of the Center for Liver Diseases, E-Da Hospital, both of which were in Kaohsiung, Taiwan. He is an active physician with a large clinical practice in inpatient and outpatient care, as well as sonography and endoscopy service. He is also an active researcher in clinical and translational research for chronic liver diseases, with a focus on chronic viral hepatitis, particularly viral hepatitis B. He has more than 100 peer-reviewed publications to his credit, including first authorship of original research articles published in leading journals such as Lance Infectious Diseases, Lancet Gastroenterology and Hepatology, Gut, Journal of Hepatology and HEPATOLOGY.
Dr. Hsu has served as an associate editor in the liver section for Digestive Diseases since 2018 and has joined the editorial board for Journal of Gastroenterology and Hepatology since 2017. He leads the research team for chronic viral hepatitis in E-Da Hospital and takes part in more than 10 multicenter trials as the principal investigator at his site. Moreover, he is eagerly participating in international collaboration and has been actively working with researchers from the United States, Canada, Japan, China, Hong Kong, and so on. His academic contributions have been recognized with awards such as the 28th Professor Sung Juei-Low's Academic Award for Excellent Research, Annual Research Award for Liver Disease Prevention and Treatment (awarded by the Taiwan Liver Disease Prevention & Treatment Research Foundation), and Young Investigator Award at the Asian Pacific Association for the Study of the Liver Single Topic Conference.
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD is a professor of medicine, and by courtesy, professor of epidemiology and population health, director for the hepatology fellowship, director for the hepatology clerkship, a member of the appointment and promotion Committee and a diversity advisor for the department of medicine at Stanford University Medical Center. She is an active clinician and researcher in viral hepatitis, nonalcoholic fatty liver disease and liver cancer with over 200 original research publications including first or senior authorship in The New England Journal of Medicine, Lancet Gastroenterology and Hepatology, Gastroenterology, Journal of Hepatology, HEPATOLOGY and JAMA NO.
Dr. Nguyen has served as editorial/advisory board member for major journals such as Lancet Gastroenterology and Hepatology, Gastroenterology and HEPATOLOGY. She has served as chair of the Hepatitis B Special Interest Group for the AASLD. She has mentored over 130 trainees from high-school students to undergraduate, medical, masters and PhD students in Public Health/Epidemiology, clinical residents and fellows, postdoctoral research fellows and faculty at assistant and associate professor rank.
Yee Hui Yeo, MD, MSc
Yee Hui Yeo, MD, MSc is a resident doctor at Cedars-Sinai Medical Center. He is an active investigator on viral hepatitis related epidemiological and health outcomes research. He is currently a trainee member of the Hepatitis B SIG Steering Committee, AASLD. He has published more than 40 peer-reviewed publications, including first or co-first authorship of original articles published in Gastroenterology, Journal of Hepatology, HEPATOLOGY and Gut.
Dr. Yeo has served as associate editor for BMC Gastroenterology. He is interested in harnessing health data analytic tools, modeling, and meta-analysis to determine the epidemiology, cascade of care, natural history, and outcomes of chronic viral hepatitis infection. He uses large databases, multicenter cohorts and EHR data from Cedars-Sinai Medical Center. He has been participating in international consortia of natural history of hepatitis B infection. His works were selected as "Best of the Liver Meeting" in AASLD annual meeting 2018. Yeo is the recipient of "Emerging Liver Scholar Award" in 2019.